Low-Dose Belantamab Mafodotin (Belamaf) in Combination With Nirogacestat Versus Belamaf Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM): Phase 1/2 DREAMM-5 Platform Sub-Study 3

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)

引用 0|浏览5
暂无评分
关键词
belantamab mafodotin,nirogacestat,RRMM,BCMA,multiple myeloma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要